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 Obesity is increasing in an epidemic fashion in most countries and constitutes a public 
health problem by enhancing the risk for cardiovascular disease and metabolic 
disorders such as type 2 diabetes 1,2. Owing to the increase in obesity, life expectancy 
may start to decrease in developed countries for the first time in recent history3.  The 
factors determining fat mass in adult humans are not fully understood, but increased 
lipid storage in already developed fat cells is thought to be most important 4,5.  
We show that adipocyte number is a major determinant for the fat mass in adults. 
However, the number of fat cells stays constant in adulthood in lean and obese and even 
under extreme conditions, indicating that the number of adipocytes is set during 
childhood and adolescence.  To establish the dynamics within the stable population of 
adipocytes in adults, we have measured adipocyte turnover by analyzing the integration 
of 14C derived from nuclear bomb tests in genomic DNA6.  Approximately 10% of fat 
cells are renewed annually at all adult ages and levels of body mass index.  Neither 
adipocyte death nor generation rate is altered in obesity, suggesting a tight regulation of 
fat cell number that is independent of metabolic profile in adulthood.  The high turnover 
of adipocytes establishes a new therapeutic target for pharmacological intervention in 
obesity. 
  
   The fat mass can expand by increasing the average fat cell volume and/or the number of 
adipocytes.  Increased fat storage in fully differentiated adipocytes, resulting in enlarged fat 
cells, is well documented and thought to be the most important mechanism whereby fat depots 
increase in adults 4,5.  To analyze the contribution of the fat cell volume in adipocytes to the 
size of the fat mass, we first analyzed the relationship between fat cell volume and body mass 
index (BMI, which reflects the fat mass) in a large cohort of adults.  As expected, there was a 
positive correlation between BMI and fat cell volume both in subcutaneous fat, which 
represents about 80% of all fat (Fig. 1a,b), and in visceral fat (Fig. 1c) which has a strong link 
to metabolic complications of obesity.  If the relationship had been linear fat cell volume 
would be the only important determinant of BMI.  In the non-linear case both fat cell number 
and fat cell size determine BMI.  The relationship was curve-linear indicating that increasing 
BMI in adulthood is a result of increased number of fat cells plus enlargement of fat cells. 
  The generation of adipocytes is a major factor behind the growth of adipose tissue during 
childhood7, but it is unknown whether the number of adipocytes changes during adulthood. 
We assessed the total adipocyte number in 687 adult individuals and combined this data with 
previously reported results for children and adolescents8.  Whilst total adipocyte number 
increased in childhood and adolescence, this number levelled off and remained constant in 
adulthood in both lean and obese (adults over 20 years, grouped in 5 year bins; ANOVA, lean 
p = 0.68, obese p = 0.21; Fig. 2a; Supplement 3).  Thus, the difference in adipocyte number 
between lean and obese individuals is established during childhood7,8 and the total number of 
adipocytes stays constant during adulthood, albeit at higher levels with increasing BMI (Fig. 
2b).  The small variation in adipocyte number during adulthood demonstrates that this is a 
stable cell population. 
  To analyze whether alterations in adipocyte number may contribute to changed fat mass 
under extreme conditions, we next asked whether fat cell number is reduced during major 
 weight loss (mean body weight loss 18% ± 11%) by radical reduction in calorie intake by 
bariatric surgery and dietary restriction.  The calorie reduction resulted in a significant 
decrease in BMI and fat cell volume, however failed to reduce adipocyte cell number 2 years 
post surgery (Fig. 2b, c: Supplement 4), in line with previous studies using different 
methodology9-12.  Thus, whereas differences in adipocyte generation in lean and obese has a 
major impact on establishing the fat mass during childhood and adolescence, the number of 
fat cells stays remarkably stable and fat mass only appears to be regulated by fat cell volume 
in adults.   This may indicate that the number of adipocytes is set by early adulthood with no 
subsequent cell turnover.  Alternatively, the generation of adipocytes may be balanced by 
adipocyte death, with the total number being tightly regulated and constant. 
   We next set out to establish whether adipocytes are replaced during adulthood, and if so, at 
what rate.  Adipocytes can be generated from adult human mesenchymal stem cells and pre-
adipocytes in vitro13 and may undergo apoptosis or necrosis14-16, but it is unclear whether 
adipocytes are generated in vivo13.  Cell turnover has been difficult to study in humans.  
Methods used in experimental animals, such as the incorporation of labelled nucleotides, 
cannot readily be adapted for use in humans due to potential toxicity.  The detection of cells 
expressing molecular markers of proliferation can give insights about mitotic activity, but fail 
to provide information regarding the fate of the progeny of the dividing cells.  This is a 
limitation when studying postmitotic cell types, which do not divide or express mitotic 
markers themselves (for example neurons or adipocytes), but may be replenished from 
proliferating stem or progenitor cells, such as preadipocytes.  We have used a recently 
developed method that is based on the incorporation of 14C from nuclear bomb tests into 
genomic DNA and allows the analysis of cell turnover in humans6,23.  14C levels in the 
atmosphere have remained relatively stable until the Cold War when above ground nuclear 
bomb tests caused a dramatic increase18,19 (Fig. 3a, b).  Even though the detonations were 
 conducted at a limited number of locations, the elevated 14C levels in the atmosphere rapidly 
equalized around the globe. After the test ban treaty in 1963, the 14C levels have dropped 
exponentially, not because of radioactive decay (half-life 5730 years), but by diffusion from 
the atmosphere20.  Atmospheric 14C reacts with oxygen to form CO2, which is incorporated 
into plants by photosynthesis.  By eating plants, and animals that live off plants the 14C 
concentration in the human body closely parallels that in the atmosphere at any given point in 
time17,21-22.  Since DNA is stable after a cell has gone through its last cell division, the 14C 
level in DNA serves as a date mark for when a cell was born and can be used to 
retrospectively birth date cells in humans6,23. 
  To address whether adipocytes are generated in adulthood, we isolated fat cells (≥98% 
purity, Supplement 4) from adipose tissue collected at liposuction or abdominal wall 
reconstruction from 35 adult lean or obese individuals.  The pure isolation of adipocytes is 
important as non-adipose cells are present in adipose tissue, and these cell types may have a 
different turnover rate (see supplement 4 for a full discussion).  Genomic DNA was extracted 
from the purified adipocytes and 14C levels were measured by accelerator mass spectrometry 
and related to atmospheric 14C data (Fig. 3c, d; Supplement 4).  We first analyzed individuals 
born well before the period of nuclear bomb tests.  This provides a high sensitivity to detect 
the generation of cells born after the time of onset of the nuclear bomb tests (1955), as 14C 
levels above those present prior to the Cold War can be detected even if only a small (1%) 
proportion of cells in a population are renewed.  In all analyzed individuals born before 1955 
(n=10), the 14C levels were substantially higher than the atmospheric levels prior to the 
nuclear bomb tests, indicating that generation of adipocytes had taken place after 1955 (Fig 
3c, see Supplement 2 for all 14C measurements and associated data).  The individuals were 0-
22 years at the onset of nuclear bomb tests, establishing that adipocytes are generated during 
adolescence and in early adulthood.  
   Analysis of individuals born before the onset of the nuclear bomb tests provides high 
sensitivity to detect cell turnover, but does not alone allow the establishment of the turnover 
rate, since a certain 14C level can correspond to the rising or falling part of the atmospheric 
14C curve.  However, the integration of data from individuals born before and after the period 
of nuclear bomb tests allow the determination of cell turnover, as well as the relative 
contribution of cell death and cell renewal to this process (see Supplement 3).  We therefore 
also analyzed 14C levels in adipocyte genomic DNA from individuals born after the period of 
nuclear bomb tests (n=25).  In all these individuals the 14C levels corresponded to surprisingly 
contemporary time points (Fig. 3d and Supplement 2), providing a first indication that there is 
continuous and substantial turnover of adipocytes in adult humans. 
  We next calculated the dynamics of fat cell turnover using a simple birth and death model 
(detailed in Supplement 3).  The model’s assumptions allow the calculation of kinetic rates for 
individual subjects. The death rate of adipocytes is approximately 0.084±0.07 per year 
(median ± average deviation) in the total fat pool of the body.  The distribution of death rates 
is skewed toward lower values and is not Gaussian (Jarque-Bera test for normality, p<0.05); 
hence the median is more informative than the mean24.  To test the reliability of the death rate 
estimates, we used three different scenarios concerning the generation of adipocytes early in 
life, and confirmed that different estimates of the death rates do not differ from the median 
(Kruskall-Wallis test, p>0.3, see Supplement 3 for description of the scenarios).  We divided 
the data set into lean (BMI <25 kg/m2) and obese (BMI ≥30 kg/m2) for analyses of the 
influence of obesity on adipocyte death rate.  No significant difference in adipocyte death rate 
was seen across the different BMIs, with obese individuals having a median adipocyte death 
rate of 0.095 ±0.05 per year, versus 0.082 ±0.06 per year for lean individuals (Kruskal-Wallis 
test for equality of medians, p=0.6; Fig. 4a).  Since adipocyte number remains constant in 
adults, the adipocyte death rate will correspond to the rate of adipocyte birth.  Thus, we 
 calculate a median adipocyte turnover rate of 8.35±6.6% per year, with 50% of adipocytes 
replaced every 8.30 years. 
  From the death rate estimates and the fat cell numbers calculated for each individual subject, 
absolute fat cell production was calculated.  Obese individuals were found to have a 
significantly greater number of adipocytes added per year than lean individuals (median 
values 0.79±0.54 vs. 0.32±0.19x1010 cells/y, (p<0.01, Kruskal-Wallis test; Fig. 4b).  Loss of 
fat cells is therefore compensated by a production of new fat cells that is twice as high in 
obese subjects compared to lean subjects.  That the total number of new adipocytes added 
each year is greater in obese individuals compared to lean, yet the proportion of newborn 
adipocytes added each year is the same for both groups, argues that the difference in cell 
number between the lean and obese adults occurred prior to adulthood.  In support of this, we 
found no significant difference in the average age of adipocytes in lean (mean 9.86±3.5y) 
versus obese (mean 9.66±4.0y) individuals (Fig. 4c).  No significant correlation between age 
of subjects and cell death or age of patients and adipocyte generation was found (Supplement 
3), suggesting a constant turnover rate throughout adult life.  
If the number of adipocytes is set to a higher level in obese people before adulthood, this is 
either because cell number expansion begins earlier (age of onset), because expansion is faster 
(growth relative to the initial cell number (IC) at age of onset), or because expansion ends 
later (age at 90% of adult cell number).  We used combined adipocyte number data (Fig. 2a) 
to see whether one or more of these factors determine adipocyte number.  Using our birth and 
death model, we determined that age at onset of adipocyte number expansion is significantly 
earlier in obese (2.1±0.9y) than in lean (5.7±0.8y) subjects; relative increase in adipocyte 
number is higher in obese (2.4±0.6 IC/y) than in lean (1.3±0.3 IC/y) subjects, but end of 
expansion of adipocyte number is earlier in obese (16.5±1.3y) than in lean subjects 
(18.5±0.7y) (predicted values ±95% confidence interval, Supplement 3).  Therefore adult cell 
 number is set earlier in obese subjects and is not due to a prolonged expansion period in 
adulthood. 
  We find that the number of adipocytes is set during childhood and adolescence and 
adipocyte numbers are subject to little variation during adulthood.  An increase in fat mass in 
young is reflected in both increased adipocyte number and volume, but changes in fat mass in 
adults are the result of altered fat cell volume.  Whereas the total fat cell number is static in 
adults, there is remarkable turnover within this population.  That total adipocyte number in 
adults stays constant, regardless of BMI and even after marked weight loss, and the 
substantial turnover within this cell population, indicates that the total fat cell number is 
tightly controlled and not influenced by the energy balance.  
  The size of organs can be regulated by different mechanisms, and the number of cells in 
some tissues is controlled by a systemic feedback mechanism25.  This is best understood for 
skeletal muscle, where growth and differentiation factor 8 (GDF8), also known as myostatin, 
is secreted from myocytes and negatively regulates the generation of new muscle cells and 
thereby sets the number of cells26.  Loss of function mutations in GDF8 results in a large 
increase in the number (and size) of myocytes in animals and humans26.  The steady 
production of adipocytes in adults results in a stable size of the constantly turning over 
adipocyte population.  Feedback mechanisms that control adipocyte turnover will be 
important to identify at a molecular level as it may offer a novel target for pharmacological 
therapy when obesity is established and for other types of intervention during childhood and 
adolescence, when the final number of fat cells in the body is being set. 
 
 
 
 
 Materials and methods 
 
Subjects 
The relationship between subcutaneous or visceral fat cell volume and BMI was studied in 
two separate cohorts and fat cell turnover was studied in a third cohort, all are described in 
Supplement 4. 
 
Isolated fat cells 
Fat cells were isolated from the adipose tissue as described in Supplement 4. Details on how 
to measure weight, volume and number of fat cells as well as determination of the purity of 
the adipocytes are given in Supplement 4. 
 
14C analysis 
Genomic DNA was prepared from isolated fat cells, purified and subjected to accelerator 
mass spectrometry analyses as described in Supplement 4 and tabled in Supplement 2.   
 
Data analysis 
The calculations of relationship between fat cell volume and BMI are described in detail in 
Supplement 1. The calculations of fat cell death and generation are described in detail in 
Supplement 3. 
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 Figure legends 
Figure 1 Fat mass is determined by both adipocyte number and size. The relationship 
between BMI and fat cell volume was curvilinear across the range of BMI's in female (a) and 
male (b) subcutaneous fat, as well as in male and female visceral fat (c), demonstrating that 
both adipocyte number and size are determinates of BMI. 
 
Figure 2 Adipocyte number remains stable in adulthood, though significant weight loss 
can result in a decrease in adipocyte volume. Total adipocyte number from 687 adult 
individuals (squares) was combined with previous results for children and adolescents7 
(circles).  Adipocyte number increases in childhood and adolescence, with the number 
levelling off and remaining constant in adulthood in both lean (blue) and obese (pink) 
individuals (a).  Major weight loss by bariatric surgery results in a significant decrease in cell 
volume (b) however fails to reduce adipocyte cell number, 1-2 years post-surgery (c).  Error 
bars = SEM, Asterisk = p <0.0001.  
 
Figure 3  Turnover of adipocytes in adulthood.  The levels of 14C in the atmosphere have 
been stable over long time periods with the exception of a large addition of 14C in 1955–1963 
as a result of atmospheric nuclear weapon tests19-20, 27 (a, b). Historical secular levels of 14C 
(a) are by convention given in relation to a universal standard and corrected for radioactive 
decay, giving the Δ14C value27.  The boxed region in plot (a) is shown in more detail in (b).  
The 14C fraction modern expressed in F14C convention defined for bomb-pulse dating28 is 
used in (b)-(d) where F14C = 1 is the natural concentration of atmospheric 14C in 1890. 
Adipocyte age in adult human subjects born before (c) and after (d) nuclear bomb tests were 
analyzed by determining the 14C concentration in adipocyte genomic DNA using accelerator 
mass spectrometry.  The measured 14C value is related to the recorded atmospheric levels to 
 establish at what time point they corresponded.  The year is read off the x axis, giving the 
birth date of the cell population.  Three representative individuals born at different times 
before the onset of the bomb tests reveals the generation of adipocytes after birth (c).  
Analysis of the oldest individuals established that adipocytes are born in adolescence and 
adulthood (c).  14C levels analyzed in people born after the period of nuclear bomb tests 
showed continuous and substantial turnover of adipocytes in adult humans (d).  The time of 
birth of the person is indicated by a vertical line in each and the BMI shown numerically (c, 
d).  Error bars for the accelerator mass spectrometry readings are too small to be visualized in 
this graph.  Each dot represents one individual.  
  
Figure 4  Effect of obesity on adipocyte generation and death.  No significant difference 
in adipocyte death rate was seen across the different BMI´s (a).  Obese individuals had a 
significantly greater number of adipocytes added per year than lean individuals (b).  No 
significant difference in the average age of adipocytes in lean versus obese individuals was 
found (c). Values are the median+/-1st and 3rd quartiles (a, b) and mean+/-SD (c). Asterisk = 
p < 0.01 for lean versus obese. 
 Supplement 1 
 
Model and curve fit for fat cell data measuring average fat cell volume against BMI 
 
Summary 
Three data sets relating BMI to the average fat cell volume were analyzed and fitted to a 
simple quantitative model.  Subjects with a wide range of BMI (from leanness to extreme 
obesity) were investigated.  The analysis strongly suggests that increasing BMI is a result of 
enlargement of fat cells plus increased number of fat cells.  
 
 
Theory 
Make the following assumptions: 
 
1. The total fat cell volume (m3), denoted η, is increasing linearly with the BMI with 
some unknown proportionality constant kB (unit: m5/kg).  Introduce an adjusted BMI 
denoted as B (unit: kg/m2) and assume B = BMI - BMI0, where BMI0 represents the 
lower theoretical limit of the BMI corresponding to η = 0, i.e. a body without fat cells. 
We have 
η = kBB 
 
2. The number of fat cells, denoted n, has a lower limit n0, which could be the number of 
fat cells from birth, and may also increase linearly with the BMI with a proportionality 
constant kg (unit: m2/kg), i.e. 
     
     (1) 
  
Note that a very low kg corresponds to the notion that fat cells hardly increase in 
number in adult humans.  
We now take interest in the average volume per cell, i.e. V = η /n and obtain 
    (2) 
This equation describes a saturation curve for the average volume per cell with respect to the 
BMI. Important to note is that when kg equals zero, we have: 
     (3) 
i.e. the average volume per cell increases linearly with the BMI if there is no increase in the 
fat cell number.  Also important to note is that the three physical parameters kB, kg, and n0, are 
not identifiable, meaning that we are not able to determine their values from data measuring 
the average cell volume V against BMI (B). Instead, we will estimate the fractions  and , 
together with BMI0.   
A potential caveat that needs to be addressed is the variability of the observable parameters 
(  and ) between individuals. Generally we have, for subject i, , where y = 
V, x = B, a =  , b =  , and e is the error in measurement, assumed to be independent from 
x. It is immediately obvious that the model is over-parameterized if a and b are allowed to 
vary freely between individual subjects i – a perfect fit can be obtained by letting ai = yi/xi and 
bi = 0. In the following, we outline how to assess the individual variability of ai and bi. Let us 
introduce the error model ai = a + ci and bi = b + di. A Taylor expansion gives  
,  (4) 
where the first term is the original model and the following three are errors. These errors can 
be assessed by observing the residuals  , where  and   are estimated from a 
 curve fit of equation (2) using a least squares method. If the residuals vary little with respect 
to xi/ (1 + bxi) and / (1 + bxi)2, respectively, individual variations in a and b are negligible; 
if they grow with any of these terms there is significant variation in a and/or b, respectively. 
Given a low individual variability in the parameters, a likelihood ratio test to compare the 
model to the null hypothesis, the special case that kg is 0 (whereby fat cells do not form in the 
adult human), can be performed accordingly: let , i.e. the residual sum of 
squares. Similarly, , corresponding to the independent fit of the null 
hypothesis that kg = 0, and thereby b = 0. If n is the number of observations, the null 
hypothesis is rejected if  
.    (5) 
 
Data Fit and Statistical Tests 
 
We partitioned our data into three data sets: one consisting of samples of visceral fat (men and 
women), one consisting of samples of subcutaneous fat (women), and one consisting of 
samples of subcutaneous fat (men). The subjects are described in Supplement 4. From each 
subject, we have the BMI value and the average cell volume. Curve fits of equation (2) to 
these three data sets were performed in the least squares sense using Matlab's statistical 
toolbox. The individual values are shown if Fig.1. The numerical values of the fitted 
parameters together with corresponding 95% confidence intervals are given in Table 1. The 
differences between the estimated parameters of different data sets were not significant (P > 
0.05).  
As described in the theory section, we checked whether the fit of equation (2) was 
significantly better than a fit to the linear equation (3). Regressions were made of the residuals 
against  x/(1+bx) and ax2/ (1 - bx)2 respectively. As presented in table 2, the coefficient of 
 determination r2} was always smaller than 0.05, which justified the straightforward use of the 
likelihood ratio test (equation 5). However, one may note that the variability of the parameters 
seems to be greater among men than among women. 
In all cases (both adipose regions and both sexes), a likelihood ratio test showed that kg is 
significantly greater than zero (P < 0.001) meaning that the relationship between fat cell 
volume and BMI differed from a linear relationship. 
 
Data set kB/n0 kg/n0 BMI0 
Visceral fat (men and 
women) 
78 ± 23 0.074 ± 0.032 18.6 ± 1.3 
Subcutaneous fat 
(women) 
106 ± 16 0.085 ± 0.018 16.0 ± 0.8 
Subcutaneous fat 
(men) 
121 ± 20 0.10 ± 0.025 17.9 ± 0.7 
 
Table 1. Estimated parameters. Intervals are 95% confidence intervals. 
 
 
 
Data set r2 for R1 r2 for R2 LR score 
Visceral fat (men and 
women) 
0.042 0.041 16.8 (P < 0.001) 
Subcutaneous fat 
(women) 
8.2 × 10-4 8.9 × 10-4 66.9 (P < 0.001) 
Subcutaneous fat 
(men) 
0.039 0.041 45.3 (P < 0.001) 
 
Table 2. Coefficients of determination r2 for the residual plots against R1 = x/(1 + bx) and R2 = 
ax2/ (1 - bx)2 of the three data sets, and outcome of the likelihood ratio (LR) test (equation 5). 
 Supplement 2 
Table showing all data from the 35 people whose adipose DNA was carbon dated. DOB = 
date of birth to the year.  For a complete explanation of the terms 'C14' and 'F14C', refer to 
Supplement 4. 
 
Table Fat sample Sex DOB Age BMI Height Body weight Fat cell volume Fat cell weight Total number of fat cells C14  +/- pMC  +/- Yr of
number number (yrs) (cm) (kg) (pl) (mg) in the body x 10 1^0 analysis
1 16 Female 1984 21 23,1 164 62 497 455 3,53 74 29 1,081 0,029 2006,3
2 22 Man 1982 23 21,1 171 62 417 382 1,89 158 12,4 1,165 0,012 2005,9
3 41 Female 1978 27 22,8 162 60 597 546 2,88 107 7,9 1,115 0,008 2005,9
4 43 Female 1976 29 24,2 176 75 505 482 4,45 122 7,5 1,129 0,007 2005,9
5 15 Female 1976 29 29,0 164 78 442 405 6,89 86 6,5 1,093 0,007 2005,6
6 53 Female 1976 29 29,1 174 88 249 228 13,86 69 6 1,076 0,006 2006,3
7 60 Man 1977 29 27,7 170 80 419 383 5,50 90 31,3 1,098 0,032 2007,0
8 34 Female 1975 30 32,8 171 96 452 414 9,65 135 13,2 1,142 0,013 2005,9
9 29 Female 1975 30 24,2 160 62 576 527 3,38 144 5,4 1,152 0,005 2005,9
10 51 Female 1974 31 35,6 165 97 733 671 6,64 80 11,5 1,087 0,012 2006,3
11 18 Female 1974 31 20,5 174 62 465 425 3,40 80 11 1,087 0,011 2006,3
12 20 Female 1973 32 24 168 68 492 450 4,33 180 5,9 1,188 0,006 2005,6
13 12 Female 1973 32 23,5 170 68 457 418 4,54 100 5,3 1,107 0,005 2005,6
14 40 Female 1973 32 25,7 165 70 488 446 4,90 161 17,8 1,168 0,018 2005,9
15 38 Female 1973 32 31,2 163 83 668 611 5,36 94 30 1,101 0,030 2006,3
16 7 Female 1971 34 38,6 168 85 486 445 7,27 86 11,7 1,093 0,012 2005,2
17 8 Female 1970 35 40,2 160 62 190 174 10,46 150 4,7 1,158 0,005 2005,2
18 47 Female 1970 35 46,7 168 98 471 431 14,35 91 68 1,098 0,068 2006,3
19 4 Female 1970 35 21,2 161 55 462 422 3,24 133 9,6 1,141 0,010 2005,7
20 36 Female 1969 36 28,2 163 75 542 496 5,37 150 10,8 1,158 0,011 2005,9
21 11 Female 1968 37 37,4 173 83 466 408 7,09 122 7 1,129 0,007 2005,2
22 14 Female 1968 37 22,1 162 58 461 422 3,64 124 4,8 1,132 0,005 2005,6
23 42 Female 1968 37 22,6 176 70 472 432 4,41 186 9,6 1,195 0,010 2005,9
24 21 Man 1968 37 26,6 187 93 707 646 3,13 171 10,0 1,179 0,010 2005,7
25 48 Man 1966 39 28,1 174 85 492 450 4,58 199 5,9 1,207 0,006 2005,9
26 27 Female 1955 50 59,6 169 107 654 599 15,08 115 7,9 1,123 0,008 2005,9
27 5 Female 1954 50 54,1 166 103 414 378 20,75 173 15 1,181 0,015 2005,7
28 13 Female 1954 51 35,4 163 65 479 438 4,73 144 6,9 1,152 0,007 2005,6
29 50 Female 1949 56 23,9 153 56 540 494 3,59 142 6,7 1,150 0,007 2005,9
30 3 Female 1948 57 35,9 160 72 535 489 5,60 150 4,7 1,157 0,005 2005,6
31 25 Female 1945 60 26,1 167 73 548 502 5,16 103 5,4 1,110 0,005 2005,6
32 46 Female 1944 61 41 166 80 550 504 6,34 179 9,4 1,187 0,009 2005,9
33 45 Man 1935 70 24,4 173 73 521 477 5,23 133 8,9 1,141 0,009 2007,0
34 19 Female 1934 71 29,4 168 83 718 657 5,28 130 18,9 1,138 0,019 2005,9
35 35 Female 1933 72 27,5 165 75 521 477 6,15 75 17,1 1,082 0,017 2007,0
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Modelling of 14C data 
Summary 
We used a mathematical model for birth and death of adipocytes to estimate adipocyte 
turnover in 35 adult subjects. Death and birth rates of adipocytes were calculated from DNA 
14C content in adipocytes, ages of patients, and absolute adipocyte number. We used three 
scenarios for the evolution of adipocyte formation at early ages and estimated rates in three 
BMI categories: lean (BMI<25 kg/m2), overweight (25≤BMI<30 kg/m2) and obese (BMI≥30 
kg/m2) subjects. We conclude that the adipocyte death rates in the three BMI groups are not 
different (Kruskal-Wallis test, p=0.6). Absolute production of new adipocytes is significantly 
higher in obese subjects than in lean subjects (Kruskal-Wallis test, p<0.01). The adipocyte 
relative turnover number, however, does not differ significantly between BMI groups (p-
value>0.1): a median value of 8.35±6.6% adipocytes is replaced each year. Using two other 
data sets, we determined the age of onset of adipocyte number expansion, and the relative 
growth in cell number during that expansion.  
 
Model 
We used a linear model with an age-structure for birth and death of adipocytes to estimate 
kinetic parameters of adipocyte birth and death. Data come from three sources: subjects who 
underwent cosmetic surgery and subsequent analysis of  14C in  subcutaneous fat cell DNA 
(D1), cross-sectional data from a study by Knittle et al (1979) (D2) (ref. 2), and from subjects 
analysed for the relationship between BMI and subcutaneous fat cell volume (D3). The 
subjects in D1 and D3 are described in Supplement 4.  Available from D1 data are average 
14C levels in adipocytes samples collected during liposuction, ages of subjects, the absolute 
body adipocyte count, and their BMI (n=35). From D2 data, we have the average adipocyte 
 number for different age groups, for normal or obese children (ages range from 0.5 to 18 y).  
D3 data consist of ages, BMI, and adipocyte numbers (n=687) using lean (BMI<25 kg/m2), 
and obese (BMI≥30 kg/m2) subjects.  We sorted D1 patients in three BMI categories: lean 
(BMI<25 kg/m2), overweight (25≤BMI<30 kg/m2), and obese (BMI≥30 kg/m2) patients.  The 
ages of subjects ranged from 21 to 72 years (average 39.9±13.8 years, at date of collection) 
and the BMI values from 20.5 to 59.6 kg/m2 (average 30.4±9.1 kg/m2).  Carbon 14 levels 
varied from 1.0763 to 1.2068 Fraction Modern Carbon (average 1.134±0.036 F14C) (Table 1). 
 
Table 1 Summary of subjects’ data D1 
n=35 Birth 
year 
Age 
(y) 
14C levels 
(F14C) 
Adipocyte number 
(x1010) 
BMI 
(kg/m2) 
Mean 1965.09 39.91 1.13435 6.36 30.39 
STD 13.86 13.81 0.03617 3.98 9.15 
Median 1970.00 35.00 1.13760 5.23 27.70 
1st quart 1954.50 30.50 1.09990 3.98 23.95 
3rd quart 1974.50 50.00 1.15792 6.76 35.50 
Min Value 1933.00 21.00 1.07630 1.89 20.50 
Max Value 1984.00 72.00 1.20679 20.75 59.60 
Lean n=13 1969.62 35.38 1.13711 3.73 22.89 
Overweight 
n=10 
1961.70 43.40 1.13099 6.08 27.74 
Obese n=12 1963.00 41.92 1.13416 9.44 40.71 
 
The age-structured model for cell birth and death has four parameters: the cell death rate , 
the initial age  at which the adipocyte distribution is known (we refer to the age of the 
patient with  and the age of adipocytes with ), the initial cell number , and the production 
of new adipocytes from a fat stem cell pool . We make the following assumptions. 
 
Period of expansion of adipocyte number: Most of the adipocytes in a young adult are 
born during a specific, critical period (starting at ) before adulthood. This means that in a 
 subject aged  years, all adipocytes have age 0 years (or perhaps very few older cells from 
childhood). 
 
Constant cell death rate: All adipocytes, regardless of their age, die at a rate  that is 
constant over the lifetime of the person. 
 
Constant cell production: Adipocytes are produced steadily at a rate  that is independent 
of the total cell number and is constant over the lifetime (after age ). This is because mature 
adipocytes do not divide and we ignore regulation of new adipocytes by mature cells. 
 
Mathematically, these assumptions may be formulated as a linear partial differential equation 
with an age-structure: 
1 
 
The initial condition at  is , where  is the Dirac delta function (i.e. all 
cells at   have age ) and  is the initial adipocyte number (unit:  cells). A 
boundary condition describes the birth of new adipocytes from progenitor cells,  
(unit:  cells/year). This equation may be solved cells with an age smaller than the time 
elapsed since . For , 
2 
, 
and the average age of a adipocyte in an adult of age  is 
3 
 
where . The newly introduce parameter  is the birth rate relative to the initial 
cell number ,  
 . 
(The parameter b is useful since  becomes independent of the total cell number.) The total 
cell number at age , is found by integrating  over the ages of adipocytes ,  
4 
 
The equation satisfies the initial condition . If , the cell number increases with 
time, else decreases. The cell number always stabilises to a constant steady state . To 
relate the age of the adipocytes with the 14C data, we used a carbon normalization curve  
(ref. 3). If the adipocyte age distribution follows Equation 2, the average 14C level  is  
5 
 
Equation 5 depends on four parameters: , , , and . The parameter  can be eliminated 
by dividing the numerator and denominator by , and by replacing the term  with  as 
in Equation 3. Thus three parameters remain to be estimated: , , and . In general, it is not 
possible from equation 5 alone to estimate all three parameters; different choices of , b, and 
 can yield the same value of . This is why additional assumptions on one or more 
parameters must be made.  
 
Default Scenario: The death rate , and the ages of the patients are sufficiently large to 
neglect the initial adipocyte population, i.e.  is very small. This means that  
becomes large and can be set to . Parameter  cancels out in Equation 5, and the 
model has only one parameter left to estimate: the death rate . This allows us to calculate an 
individual death rate for each patient. The adipocyte production can then be estimated from 
 the adipocyte count of each subject. Under Default Scenario, , for , and 0 
otherwise.  
By comparing the results with those obtained with different assumptions, we may be able to 
identify information that is statistically significant. In addition to the Default Scenario, we 
used the following alternative scenarios: 
Scenario A: Same as Default Scenario, except that an average death rate is calculated instead 
of individual values for each subject. 
 
Scenario B: The cell turnover as we model it starts in a patient at age , and for age  
the total cell number is constant, i.e. . Thus  and  need to be fitted. 
 
Scenario C: The cell turnover as we model it starts in a patient at age , which has to be 
guessed. Parameters  and  are fitted. 
 
As shown below, the model is robust with respect to  (changing  does not affect the 
estimates of other parameters), as long as this parameter is far from the ages of patients at 
time of harvest. The consequences of each case are felt on the cell numbers. In the Default 
Scenario and Scenario A, the population increases to reach a steady state. In Scenario B, the 
population is constant, by definition, for . In Scenario C, the population can either 
increase or decrease before reaching the steady state. 
 
Results 
Ages of subjects and BMI distribution 
Subjects were divided according to their BMI and age.  Data D1 are summarized in Table 1. 
Overweight patients tend to be older than lean and obese patients, but not significantly 
(ANOVA, p>0.05).  Similarly, we found no significant differences in 14C levels between 
young and old patients and between lean and obese subjects (ANOVA, p=0.8). 
 Estimating birth and death rates 
Table 2 Summary of the adipocyte kinetic rates for three groups of subjects: lean (BMI<25 
kg/m2), overweight (25≤BMI<30 kg/m2), and obese (BMI≥30 kg/m2). Units are γ ,  
cells/y,  ICP/y; and  and  y. [CI] 95% confidence interval on the parameters, STD 
standard deviation, AD absolute deviation, g. guessed. *Kruskal-Wallis test p<0.01. 
 
 Default Scenario 
 
Scenario A 
Error! Bookmark 
not defined. 
Scenario B 
 
Scenario C 
Error! Bookmark not defined. 
BMI category  mean±STD 
(median±AD) 
mean±STD 
(median±AD) 
 fit 
[CI] 
mean 
(median) 
fit 
[CI] 
mean 
(median
) 
 
fit 
fit 
[CI] 
mean 
(media
n) 
fit  g. 
lean (n=13) 0.097±0.08 
(0.0823±0.056) 
0.394±0.26* 
(0.319±0.19) 
0.075 
[0.03] 
0.308 
(0.290) 
0.080 
[0.04] 
0.299* 
(0.287) 
4.6 0.081 
[0.05] 
0.292* 
(0.288) 
0.065 9 
overweight 
(n=10) 
0.138±0.1 
(0.1195±0.085) 
1.113±1.50 
(0.623±0.94) 
0.090 
[0.04] 
0.572 
(0.489) 
0.091 
[0.05] 
0.554 
(0.485) 
12.9 0.104 
[0.06] 
0.543 
(0.507) 
0.031 9 
obese (n=12) 0.114±0.06 
(0.0946±0.051) 
1.057±0.64* 
(0.793±0.54) 
0.0894 
[0.04] 
0.872 
(0.671) 
0.078 
[0.06] 
0.740* 
(0.563) 
13.3 0.077 
[0.04] 
0.804* 
(0.637) 
729.4 9 
all (n=35) 0.114±0.08 
(0.0835±0.066) 
0.827±0.93 
(0.502±0.58) 
0.085 
[0.02] 
0.569 
(0.447) 
0.088 
[0.02] 
0.562 
(0.462) 
16.6 0.089 
[0.03] 
0.569 
(0.468) 
0.088 9 
 
Table 3 Age of adipocytes, average years ±STD, (median) 
BMI category Default Scenario Scenario 
A 
Scenario 
B 
Scenario 
C 
lean (n=13) 9.86±3.5 
(10.24) 
10.22±1.4 
(10.14) 
8.15±2.1 
(8.41) 
9.74±1.1 
(9.88) 
overweight (n=10) 8.96±4.6 
(8.69) 
9.79±0.9 
(9.70) 
9.27±1.6 
(9.36) 
10.30±0.8 
(10.36) 
obese (n=12) 9.67±4.0 
(9.82) 
9.94±0.7 
(9.68) 
9.61±1.2 
(9.27) 
10.48±0.6 
(10.31) 
all (n=35) 9.54±3.9 
(10.24) 
9.96±1.0 
(9.90) 
8.97±1.8 
(9.09) 
10.15±0.9 
(10.22) 
 
Since it is not possible to estimate all three parameters at once from equation for , we used 
the Default Scenarios and the three scenarios described above. For each of them, the 
adipocyte death rate, , can be estimated. Moreover, in Default Scenario,  is the only 
parameter, allowing estimates for individual patients unlike the alternative scenarios. (In 
Scenario A, we calculated a single average death rate using the same assumptions as in 
Default Scenario). In Scenario B,  is estimated together with , while  by definition. 
 Finally in Scenario C,  and  are estimated together, while  is assigned a guessed, fixed 
value. For each scenario, we calculated the death rates  for the lean, overweight, obese, and 
all subjects. We estimated the death rates using the nonlinear fitting algorithm nlinfit from 
Matlab (www.mathworks.com). 
Once the death rate estimated, we used the estimated number of adipocytes in each patient 
(Supplement 4 contains the procedure for adipocyte number calculation) and their age to 
calculate the absolute birth rate . This was performed by taking the total number of 
adipocytes given by the model (  in Equation 4) and solving for . This leads to three 
formulas.  
6 
 
7 
 
8 
 
 
The equations are the direct consequence of the assumptions on each scenario. Results are 
displayed in Table 2. The average age of adipocytes  was directly calculated from , and 
 using Equation 3 ( 
Table 3). 
 
Statistical analysis 
The death rates calculated from various scenarios are very similar, with values just below 0.09 
per year (Table 2). This is encouraging, because estimating the absolute birth rates requires 
robust estimates of the death rates, cf. Equations 6, 7, and 8.  No significant difference in 
death rates could be found between the lean and obese subjects (Kruskal-Wallis test for 
equality of medians, p=0.6). No significant differences in ages of adipocytes were found 
 between different BMI categories (average age 9.86±3.5, 8.96±4.6 and 9.67±4.0 years for 
lean, overweight and obese subjects respectively,  
Table 3), which is a consequence of the 14C levels being constant between BMI groups.  A 
constant death rate across BMI categories should correspond to a higher adipocyte production 
in patients with high BMI. Four estimates were obtained for the birth rate . Estimates varied 
between 0.29x1010cells/y in lean subjects to 1.05x1010cells/y in obese patients. For Default 
Scenario, the difference in  between lean and obese subjects is significant (median 0.32 to 
0.79x1010cells/y, Kruskal-Wallis test, p=0.0016, Table 2).  When divided into two groups 
with BMI below and above 27 kg/m2, the difference is also significant (Kruskal-Wallis test, 
p=0.01). The difference in  between lean and overweight, and obese subjects, however, is 
not significant (p=0.3).  
It is possible that the turnover is not uniform among the adipocytes sampled. The 14C labelling 
method measures the ages of cells present in samples and, by extension, their death rates. 
Strawford et al2 used heavy water (2H2O) to label newly synthesised DNA with deuterium and 
reported extremely high turnover rates, 58%--105% per year, in subcutaneous adipose tissue 
aspirates in humans. Differences in tissue samples cannot account for the observed difference 
in rates, thus the difference in turnover rates suggests that the newborn adipocytes, i.e. 
differentiated post-mitotic pre-adipocytes, have higher turnover than the mature adipocytes. 
Including fast proliferating cells present in a proportion reported; 10-17% newly divided cells 
after 9 weeks of labelling2, would affect our estimates by less than 10%. The actual 7-12 fold 
difference in turnover rates might represent the excess ratio of pre-adipocyte to adipocyte 
produced. These turnover rates indicate that most proliferating pre-adipocytes do not 
permanently join the adipocyte population. Nuclear bomb test 14C and heavy water labelling 
are complementary approaches suitable to detect cell turnover in the older, mature adipocyte 
fraction and to estimate the faster turnover of the proliferating fraction. 
 In summary, the 14C samples allowed us to estimate reliably two parameters of the model: the 
annual death rate  and the annual adipocyte production . We only obtained poor estimates 
for the two remaining parameter,  and , because of the finite memory of the adipocyte 
population. These parameters depend on childhood and cannot be estimated in adults. To get 
an estimate for these two parameters, we used cross-sectional data coming from children and 
adults.    
Estimating  and  from cell number data 
Since  and  cannot reliably be estimated from the C14 sample, we used cross-sectional data 
on cell numbers in subjects with wide range of age (data set D2 and D3, Table 4) to see how 
the modelled cell number  varies over age.  The aggregated data were divided into two 
groups, normal and obese (normal, BMI<25 kg/m2; obese, BMI>30 kg/m2), corresponding to 
the division used by Knittle et al1.  
 
Table 4 shows a summary of the data, divided according to age and BMI.  Cell number does 
not change significantly between age groups in data set D3 (multi-group ANOVA, p=0.68).  
No data are provided for obese aged less than 3 since no obese were detected at this early age.  
We thus used data from the normal group for obese below 3 years old. We fitted the four 
parameters of the cell number  to these data and got estimates of 5.7±0.8y and 
2.1±0.9 y and  1.3±0.3 and 2.4±0.6 IC/y for normal and obese respectively ( 
Figure 1).  Using the fitted adipocyte number curves, we calculated the age at which 75% or 
90% of adult cell number is reached in lean and obese subjects.  The adult adipocyte cell 
number was at 16.5±1.3y (90%) and 10.5±1.3y (75%) in the obese and at 18.5±0.7y, (90%) 
and 14.5±0.7y, (75%) in the lean.  The errors are the 95% confidence intervals on the 
 predicted ages.  The value of  is consistent with the conclusions of Knittle et al1 that cell 
number expansion starts earlier in obese than in lean children.  
 
Table 4 Adipocyte number for different age groups and BMI categories. Data in italic are D21, 
and in bold D3 (present study) 
 normal obese 
age n cell 
number 
STD n cell 
number 
STD 
0.5 18 0.4 1.4 - - - 
1 27 0.5 1.5 - - - 
3 31 0.9 1.2 17 1.85 1.2 
6 29 1.1 3.1 23 3.4 3.3 
9 29 1.2 3.2 15 3.95 3.1 
12 22 2.8 2.6 27 6.2 5.1 
15 16 3.5 3.0 29 6.8 4.3 
18 6 4.0 2.0 9 8.0 3.0 
18 6 4.4 2.1 - - - 
22 21 4.1 2.1 20 8.7 3.4 
27 42 4.6 1.7 49 7.6 2.0 
32 44 5.2 2.3 55 7.3 2.4 
37 24 5.0 1.5 56 7.3 2.3 
42 56 4.2 1.8 59 7.3 2.1 
47 27 4.3 1.6 47 7.7 2.4 
52 16 4.4 2.4 22 7.5 2.7 
57 9 4.9 2.1 21 7.1 2.3 
60+ 8 4.2 0.9 13 6.0 2.4 
 
  
Figure 1  Results of the fitting of the cell number data by N(t)  
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Subjects  
The relationship between BMI and fat cell volume was determined on two study groups.  
Abdominal subcutaneous adipose was obtained from 204 men and 486 women (age 16-72 
years, mean 39 years) by biopsy under local anesthesia.  Visceral (omental) adipose tissue 
was obtained at the beginning of elective abdominal surgery because of a non-malignant 
disorder from 36 men and 107 women (age 16-32 years, mean 39 years).  The effect of weight 
reduction was studied in 9 men and 11 women (age 26-57 years, mean 43 years) who were 
operated for obesity using gastric banding.  An abdominal subcutaneous fat biopsy was 
obtained as above before operation when BMI was 42.2 ± 4.5 (mean ± SD) kg/m2 and 2 years 
thereafter when BMI was 34.6 ± 6.0 kg/m2.   For 14C analysis, a large piece (about 200 g) of 
subcutaneous adipose tissue was obtained from 35 separate individuals (age 21 - 72 years).  
This group included 25 women and 2 men who underwent abdominal subcutaneous 
liposuction for cosmetic reasons, and 6 women who underwent abdominal wall reconstructive 
surgery 1-2 years after bariatric surgery for obesity, when weight reduction had caused skin 
folding of the abdomen.  The latter group of subjects was classified as obese regardless of 
their BMI at the time of reconstructive surgery, since their surgical diagnosis was massive 
obesity and we can show in this study that weight reduction does not influence fat cell 
number.  The studies were explained to each subject and his/hers consent was obtained. 
Ethical permission for all studies was approved by the ethics committee at Karolinska 
Institute. 
 
Isolation of adipocytes from adipose tissue 
Fat cells were isolated from the remaining components of the tissue according to the 
collagenase procedure of Rodbell1.  In brief, tissue was cut into ≈ 20 mg pieces and incubated  
 (1 g tissue/ml medium) in Krebs-Ringer phosphate (KRP buffer (pH 7,4) containing 4% 
bovine serum albumin (BSA) and 0.5 mg/ml of collagenase type 1 for 60 min at 37oC in a 
shaking water bath.  The isolated fat cells were collected on a nylon mesh filter and were 
washed 4-5 times with 0.1% KRP-BSA buffer.  The purity of the isolation procedure was 
estimated by investigating 200 cells under a light microscope in each subject.  The number of 
isolated cells not resembling fat cells or cell material that was stuck to a fat cell was always 0-
2 per 200 counted cells. 
In order to exclude possible contamination with even small numbers of non-fat cells in the 
preparations of mature fat cells, a number of techniques were used. Results are presented in 
Table 1. As a first step, 106  isolated mature fat cells were centrifuged at 200 g for 10 min. The 
resulting pellet, predominantly containing contaminating non-fat cells was very small and 
hardly discernable by visual inspection and was termed the contaminating fraction. The pellet 
was resuspended in a small amount of minimal essential medium (with no phenol red) and 
stained with 0.3 mg/ml of MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-
tetrazoliumbromide)) for 1 hr at 37C. Cells were lysed with isopropanol and staining was 
determined spectrophotometrically at 592 nm as described previously2.  The amount of living 
cells in these preparations was compared with known amounts of isolated preadipocytes (see 
above) isolated from the same specimen and resuspended in different test tubes.  With this 
semiquantitative titration comparison, the total number of surviving cells in the “contaminant” 
fraction was low and corresponded to 13-16 x104, i.e. a contamination degree of 
approximately 1.3-1.6%.  In order to determine what type of cells the contaminant fraction 
was composed of, we performed flow cytometry.  For this, contaminant fractions were 
obtained from approximately 10x106 cells.  These cells were washed and re-suspended in 
phosphate buffered saline (PBS) and incubated on ice for 30 minutes with conjugated, 
monoclonal antibodies against CD34 (preadipocyte marker), CD45 (common leukocyte 
 marker), CD31 (endothelial cell marker) (all antibodies from Becton Dickinson, San Jose, 
CA, USA). Nonspecific fluorescence was determined, using equal aliquots of cell preparation 
incubated with anti-mouse monoclonal antibodies (Becton Dickinson, San José, CA, USA).   
Finally, the cells were assayed on a FACS Calibur flow cytometer (Beckton Dickinson, San 
José, CA, USA) and using Cellquest software (Becton Dickinson, San José, CA, USA).  This 
analysis revealed that the contaminating fraction consisted of approximately 5-6 x 104 cells 
out of which 67-87% were living cells.  The percentage of contaminating cells in total would 
be less than 0.5% if estimated in this manner.  This was in accordance, albeit somewhat less, 
than the numbers estimated with the MTT assay.  When comparing the cell numbers with the 
total amount of mature fat cell from which the contaminant fractions were obtained, the 
contamination degree for cells positive for each epitope was the following; CD34-0.041%; 
CD31-0.11% and for CD45-0.017%.  The number of putative leukocytes present in the 
contaminant fraction was finally assessed by incubation with CD45-Dynabeads (Dynal 
Biotech, AS, Oslo, Norway).   In brief, 105 mature fat cells were resuspended  in PBS+0.1% 
BSA. 1X107 Dynabeads were washed in PBS+0.1% BSA and added to eppendorf vials.  
After letting the tubes stand in a magnetic rack for 1 minute, the supernatant was removed and 
the mature fat cells were added to a final volume of 1 ml. Cells were allowed to incubate in 
the presence of Dynabeads for 20 minutes at +4C after which the tubes were put in magnetic 
racks. The supernatant was removed and the pellet, containing rosetted leukocytes was 
resuspended in Dulbecco´s modified Eagles medium (DMEM/F12) and plated on to cell 
culture plates. After allowing the cells to sink for an hour at 37C the number of rosetted 
leukocytes was counted.  With this method the number of leukocytes in the contaminating 
fraction was estimated to <0.1%.  Finally, the methods employed above indicate that a small 
proportion of cells, probably 1% or less are present in washed and packed fat cells.  However, 
it is still possible that a small number of cells may attach to large fat cells and thereby still be 
 present in the mature fat cell fraction.  In order to exclude this possibility, washed 
preparations of mature fat cells were stained with the nuclear stain 4’6-Diamino-2-
phenglindole (DAPI) from (SIGMA, St Louise, MO, USA).  In brief, mature adipocyte 
fractions were fixed in cell fix (BD Biosciences) for 20 min, followed by washes in PBS. 
DAPI (stock dissolved in methanol) was added at 100 ng/ml final concentration for 20 min 
followed by repeated washes in PBS.  Cells were then mounted on microglass slides.  
Inspection by fluorescent microscopy in 10 random fields revealed clearly discernable nuclei 
in mature fat cells but no nuclei corresponding to contaminating cells on the surface of any fat 
cell or in between the adipocytes, clearly demonstrating that the mature fat cell preparations 
are more or less exclusively composed of mature fat cells with a very low degree of 
contaminating cells (Fig. 1). 
 
Method Contamination degree (mean %) Range (%) N 
MTT 1.45 1.3-1.6 2 
FACS   3 
CD34 0.041 0.0067-
0.07- 
 
CD31 0.11 0.011-0.2  
CD45 0.017 0.0061-
0.027 
 
Dynalbeads <0.1  2 
 
Table 1. Assessment of contamination of non-fat cells in the isolated fat cell preparation, 
using a variety of techniques, as descried in the text. N = number of experiments. 
 
Measurement of fat cell weight, volume, and number  
Mean fat cell volume and weight was determined on isolated fat cells as follows: Fat cell 
diameter was determined during direct microscopy and the mean diameter of 100 cells in each 
individual was determined. The mean fat cell volume and weight were calculated by formulas 
developed by Hirsch and Gallian3. Coefficient of variation for the method is 2-3%. The mean 
values are essentially the same as those determined from fat cell sizing of intact pieces of 
 human adipose tissue4. Total number of fat cells in the body was calculated in the subjects 
participating in the 14C study and in the study presented in Fig.2 using a formula based on 
age, BMI and sex to determine percentage of body fat5. In a separate methodological study we 
evaluated this formula by comparing percentage body fat obtained by the formula and by 
dual-X-ray absorbmetry in 7 men and 14 women with BMI 17-46 kg/m2 and age 22-79 years. 
There was an excellent correlation between the two measures (r=0.95 by linear regression) 
with slope and intercept near 1.0 and zero, respectively. The coefficient of variation for the 
two measures was 4.1% in non-obese and 3.7% in obese (the group divided at BMI 30 kg/m2). 
The amount of fat cells in the body was calculated as (% body fat x body weight) /mean fat 
cell weight. The mean fat cell weight was determined in the abdominal subcutaneous fat 
sample used for 14C analysis. It is well known that mean fat cell volume and weight differs 
between various adipose regions in man. However, the differences are small and only 
introduce a marginal error when just one depot is used for the calculation of total fat cell 
number as discussed6.  In the whole cohort total fat cell number  (mean+SD) was 5.6+2.6 x 
1010, which is in the same range as in several other studies as discussed6. For the obese group 
investigated before and after gastric banding body fat was determined by bioimpedance and 
fat cell number as described above. 
 
 
Condition 
BMI  
kg/m2 
Fat cell volume 
picolitres 
Fat cell number  
x1010  
 
Before gastric 
banding 
42.2±1.0 890±28 8.4 ±0.5 
After gastric 
banding 
34.6±1.3 617±38 8.5±0.6 
p-value by Student´s 
paired t-test 
<0.0001 <0.0001 0.98 
 
Table 2.  Effects of gastric banding on BMI, fat cell volume and total fat cell number before 
and 2 years after surgery on obese subjects. The weight loss was 18±11 %.  Values are mean 
± SEM. 
 DNA extraction 
Purified adipocytes were stored at -80 degrees in 25-35ml aliquots. Frozen adipocytes were 
placed into plastic bags and mechanically disrupted with a hammer. One ml of digestion 
buffer (500mM NaCl, 50mM Tris.Cl pH 8.0, 125mM EDTA pH 8.0, 2.5% SDS, 0.5mg/ml 
proteinase K) per 8ml of adipocytes was added to the plastic bag and the sample incubated at  
+55 degrees overnight (12hrs). The samples were then extracted with equal amounts of 
volume of phenol/chloroform/isoamylalcohol. This procedure was repeated until no more 
protein was seen in the interphase between the two layers. A further extraction was performed 
using chloroform only. DNA was precipitated by adding half the volume of 7.5M ammonium 
acetate and two volumes of 95% ethanol to the aqueous phase. DNA was washed thoroughly 
(4 -6 washes in 70% ethanol for 30-60 mins) before being air dried at +50 degrees. DNA was 
resuspended in 0.5-1.0 ml DNAse-free pure water and incubated at +60 degrees for several 
days. DNA purity was confirmed using a spectrophotometer and HPLC analysis.  
 
AMS analysis of 14C content 
Purified DNA samples suspended in 1.0-1.5 mL water glass vials were lyophilized to dryness, 
resuspended in 0.25 mL of 18.2 MΩ DDI water and transferred to quartz AMS combustion 
tubes.  Each glass vial was rinsed 3x with 0.25 mL of 18.2 MΩ DDI water and the rinsate was 
added to resuspended DNA in the quartz combustion tubes.  The DNA and rinsate were again 
lyophilized to dryness.  AMS isotopic standards Oxalic Acid II (NIST SRM 4990 C) and 
ANU sucrose underwent the same drying and transfer as the DNA. Excess copper oxide 
(CuO) was added to each dry sample, tubes were evacuated and sealed with a H2/O2 torch.  
Tubes were placed in a furnace set at 900 C for 3.5 h to combust all carbon to CO2. The 
evolved CO2 was purified, trapped, and reduced to graphite in the presence of iron catalyst in 
individual reactors7.  Magnesium perchlorate water traps were used during graphite 
 production8.  Large CO2 samples (> 500 µg) were split and δ13C was measured by stable 
isotope ratio mass spectrometry. Graphite targets were measured at the Center for Accelerator 
Mass Spectrometry at Lawrence-Livermore National Laboratory.  
Few of the DNA samples were large enough to get δ13C splits, but those measured ranged 
from –21 to –23 per mil, values similar to the whole tissues.  We used a δ13C fractionation 
correction of –23 +/-2 for all samples.  Corrections for background contamination introduced 
during AMS sample preparation were made following the procedures of Brown and Southon9.  
All 14C data are reported in units of fraction modern carbon (F14C) with δ13C fractionation 
correction. The supplemental information expresses 14C data in other nomenclatures, as decay 
corrected ∆14C following the dominant convention of Stuiver and Polach10 and as F14C post-
bomb fractionation corrected data11.  The ∆14C convention established for reporting 
radiocarbon data in chronological and geophysical studies was not developed to deal with 
post-bomb data, but it is the most commonly used. The relatively new F14C is a clearly 
defined standard nomenclature for post-bomb data11. 
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